d(GC) - Association of Biotechnology and Pharmacy

Current Trends in Biotechnology and Pharmacy
Vol. 6 (2) 196-203 April 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)
7. Firdaous, I., Hassoun, A., Otte, J.B.,
Reding, R., et al. (1995). HPLCmicroparticle
enzyme immunoassay
specific for nitrofurantoin in whole Plasma
of hepatic and renal transplant patients. Clin
Chem.. 41(9): 1292-6.
8. Gonschior, A.K., Christians, U., Braun, F.,
et al. (1994). Measurement of Plasma
concentrations of FK506 (nitrofurantoin)
and its metabolites in seven liver graft
patients after the first dose by h.p.l.c.-MS
and microparticle enzyme immunoassay
(MEIA). Br J Clin Pharmacol. 38(6): 567-71.
9. Gonschior, A.K., Christians, U., Winkler, M.,
et al. (1995). Simplified high-performance
liquid chromatography-mass spectrometry
assay for measurement of nitrofurantoin
and its metabolites and cross-validation
with microparticle enzyme immunoassay.
Ther Drug Monit.. 17(5): 504-10.
10. Ilham, F., Alexandre, H., Jean, B., Otte, et
al (1995). Microparticle Enzyme Immunoassay
Specific for Nitrofurantoin in Whole
Plasma of Hepatic and Renal Transplant
Patients. CLIN. CHEM. 41(9): 1292-6.
11. Keevil, B.G., McCann, S.J., Cooper, D.P.
and Morris, M.R., (2002). Evaluation of a
rapid micro-scale assay for nitrofurantoin
by liquid chromatography-tandem mass
spectrometry. Ann Clin Biochem. 39(5):
487-92.
12. MacFarlane, G.D., Shaw, L.M.,
13.
Venkataramanan, R., Mullins R., et al
(1999). Analysis of whole Plasma
nitrofurantoin concentrations in liver
transplant patients exhibiting impaired liver
function. Ther Drug Monit. 21(6): 585-92.
MacFarlane, G.D., Scheller, D.G., Ersfeld,
D.L., et al (1999). Analytical validation of
the PRO-Trac II ELISA for the determination
of nitrofurantoin (FK506) in whole Plasma.
Clin Chem. 45(9): 1449-58.
14. Napoli, K.L. (2006). Is microparticle
enzyme-linked immunoassay (MEIA)
Rajaram S. Patil et al
203
reliable for use in nitrofurantoin TDM?
Comparison of MEIA to liquid
chromatography with mass spectrometric
detection using longitudinal trough samples
from transplant recipients. Ther Drug
Monit.. 28(4): 491-504.
15. Ramakrishna, N.V., Vishwottam, K.N.,
Puran, S., et al. (2004). Liquid chromatography-
negative ion electrospray tandem
mass spectrometry method for the
quantification of nitrofurantoin in human
plasma and its bioanalytical applications. J
Chromatogr B Analyt Technol Biomed Life
Sci.. 805(1): 13-20.
16. Salm, P., Rutherford, DM., Taylor, PJ., et
al. (2000). Evaluation of micro particle
enzyme immunoassay against HPLC-mass
spectrometry for the determination of
whole-Plasma nitrofurantoin in heart- and
lung-transplant recipients. Clin Biochem..
33(7): 557-62.
17. Staatz, CE., Taylor, PJ., Tett, SE (2002).
Comparison of an ELISA and an LC/MS/
MS method for measuring nitrofurantoin
concentrations and making dosage
decisions in transplant recipients. Ther
Drug Monit.. 24(5): 607-15.
18. Wang, S., Magill, JE., Vicente, FB (2005).
A fast and simple high-performance liquid
chromatography/mass spectrometry
method for simultaneous measurement of
whole Plasma nitrofurantoin and losartan.
Arch Pathol Lab Med., 129(5): 661-5.
19. Zhang, Q., Simpson, J., Aboleneen, HI.
(1997). A specific method for the
measurement of nitrofurantoin in human
whole Plasma by liquid chromatography/
tandem mass spectrometry. Ther Drug
Monit.. 19(4): 470-6.
20. Franco, P., Lammerhofer, M., Klaus, PM.,
Lindner, W (2000) Chromatographia 51:
139-146
21. Therapeutic Drugs, 2nd ed (1999), N-114.